ARTICLE | Company News
Galapagos, EXEL functional genomics deal
January 23, 2002 8:00 AM UTC
Galapagos (Mechelen, Belgium) will use its PhenoSelect technology to manufacture replication-deficient adenoviral vectors carrying genes selected by Exelixis (EXEL). EXEL will use the adenoviral vecto...